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Background: nutritional support (NS) is a core element in the treatment of underweight patients with anorexia nervosa (AN). 
Objective: to analyze the adherence of NS prescriptions to clinical practice guidelines (CPGs) for AN patients and to compare the effectiveness, 
safety, and cost of NS according to adherence.
Methods: this retrospective observational study included AN patients admitted to an Eating Disorders Unit between January 2006 and December 
2009 and followed until December 2014. NS prescriptions were compared with guidelines published by the American Psychiatric Association 
(APA), the National Institute for Clinical Excellence (NICE), and the Spanish Ministry of Health and Consumption (SMHC). Adherence was defined 
as percentage of hospitalizations that followed all recommendations. 
Results: adherence to APA and NICE/SMHC was observed in 10.2% and 73.4%, respectively, of the total of 177 hospitalizations. Body weight 
and body mass index were higher at admission in the NICE/SMHC adherence versus non-adherence group (p < 0.001). Weight gain rate during 
hospitalization was higher (p = 0.009) in “APA adherence” (135.5 g/day) versus “non-adherence” (92.1 g/day) group. Hospital stay was sig-
nificantly shorter (p = 0.025) in “NICE/SMHC adherence” (39.5 days) versus “non-adherence” group (50.0 days). NICE/SMHC adherence was 
associated with lower costs (p = 0.006). 
Conclusions: NS prescriptions for anorexic patients more frequently followed NICE/SMHC than APA recommendations. Over the short-term, APA 
adherence was associated with improved weight gain. Patients adhering to NICE/SMHC recommendations had shorter hospital stay and reduced 








Introducción: el soporte nutricional (SN) es un elemento clave en el tratamiento de la anorexia nerviosa (AN).
Objetivo: analizar la adecuación de las prescripciones de SN en pacientes con AN a las guías de práctica clínica (GPC) y comparar la efectividad, 
seguridad y coste según la adecuación.
Métodos: estudio observacional retrospectivo en pacientes con AN ingresados en una Unidad de Trastornos de Conducta Alimentaria entre enero 
de 2006 y diciembre de 2009. Se hizo seguimiento hasta diciembre de 2014. Se compararon las prescripciones de SN con las GPC publicadas 
por la Asociación Americana de Psiquiatría (APA), el Instituto Nacional de Excelencia Clínica (NICE) y el Ministerio Español de Sanidad y Consumo 
(MSC). Se definió adecuación como porcentaje de ingresos que cumplieron todas las recomendaciones.
Resultados: el grado de adecuación a APA y NICE/MSC fue del 10,2% y 73,4%, respectivamente. El peso corporal y el índice de masa corporal 
al ingreso fueron mayores en el grupo “sí-adecuación” al NICE/MSC versus “no-adecuación” (p < 0,001). La tasa de ganancia ponderal fue 
superior (p = 0,009) en el grupo “sí-adecuación” a APA (135.5 g/día) versus “no-adecuación” (92,1 g/día). La estancia hospitalaria fue menor 
(p = 0,025) en “sí-adecuación” al NICE/MSC (39,5 días) versus “no-adecuación” (50,0 días). La adecuación al NICE/MSC fue asociada con 
menores costes (p = 0,006). 
Conclusiones: las prescripciones de SN se ajustaron en mayor grado al NICE/MSC que a la APA. La adecuación a APA parece relacionarse 
con mayor tasa de ganancia ponderal. Los pacientes que se adecuaron al NICE/MSC presentaron menores estancias hospitalarias y costes, 
probablemente relacionado con su estado nutricional más favorable al ingreso.
Note: This article forms part of the doctoral thesis of María del Mar Alañón Pardo, Pharmacy Doctoral 
Program, University of Granada, Spain.
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INTRODUCTION 
Anorexia nervosa (AN) is a life-threatening eating disorder as-
sociated with a higher chronification risk and mortality rate in 
comparison to other eating disorders (1-3). Its association with 
high hospital admission rates, long hospital stays, increased 
health costs, and severe physical, psychological, and social se-
quelae makes it an important social and health problem. Up to 
two-thirds of patients with AN are admitted to hospital at least 
once during the course of their disease (3,4). 
Available treatments have very low success rates; thus, one re-
view reported relapse in around half of AN patients within the first 
year after inpatient treatment (5). Little information is available on 
factors that may be associated with a favorable response. Low 
body weight at hospital discharge has been related to higher re-
lapse and readmission rates (6,7), but the achievement of weight 
gain during hospitalization poses a major challenge in patients 
with AN (5).
Clinical practice guidelines (CPGs) of the UK National Insti-
tute for Clinical Excellence (NICE, 2004; last revision in 2013), 
the American Psychiatric Association (APA, 2006; last revision 
in 2012), and the Spanish Ministry of Health and Consumption 
(SMHC, 2009) (8-10) provide evidence-based recommendations 
on the approach to patients with eating disorders. According to 
these CPGs, patients with AN require a multidisciplinary approach 
that includes dietary-nutritional and psychological therapies.
The therapeutic objective of nutritional support (NS) in hos-
pitalized AN patients is to recover a healthy minimum weight, 
correcting the physical and psychological sequelae of malnutrition. 
An improvement in nutritional status has been found to enhance 
the cognitive status of these patients, increasing the effectiveness 
of psychological therapies (8-12).
Natural feeding should be the first option for NS, because it fa-
vors psychosocial abilities and behaviors that are hindered by arti-
ficial feeding. However, the diet can be supplemented with artificial 
nutrition, preferably enteral, in patients with a long history of early 
satiety, inadequate weight recovery, or severe malnutrition, or in 
those who will not cooperate with food intake (8,10,12). Thus, it 
has been reported that hypercaloric supplements are useful to 
recover weight and reduce hospital stays (12-15). Furthermore, 
multivitamin and mineral oral supplements (mainly phosphorus, 
potassium, and magnesium) have been used to prevent refeeding 
syndrome and treat nutritional deficiencies in highly malnourished 
patients (8-12), while zinc supplementation was reported to be 
effective for weight recovery in patients with AN (16,17).
We hypothesized that adherence of NS prescriptions to CPG 
recommendations for eating disorders would improve health out-
comes and reduce costs. Few published data are available on the 
adherence to recommendations of NS prescriptions for patients 
with AN and its influence on long-term effectiveness and safety 
outcomes. With this background, the objectives of this study were 
to analyze the adherence of NS prescriptions for hospitalized AN 
patients to recommendations in APA, NICE, and SMHC CPGs and 
to compare the effectiveness, safety, and costs of NS as a function 
of CPG adherence.
MATERIALS AND METHODS
STUDY DESIGN AND POPULATION
This retrospective observational study included patients with 
AN admitted to a ten-bed in-patient Eating Disorders Unit (EDU) 
in a general university hospital between January 2006 and De-
cember 2009 and followed until December 2014. This unit is a 
nationally recognized specialist center for adolescents and adults 
with severe eating disorders. 
Inclusion criteria were: age ≥ 12 years; weight < 85% ide-
al weight, i.e., body mass index (BMI) ≤ 17.5 kg/m2 according 
to the 10th edition of the International Classification of Diseases 
(ICD-10, WHO, 1992), and fulfillment of all diagnostic criteria for 
AN (restrictive [R-AN] and purging [P-AN] subtypes) according to 
the American Psychiatric Association Diagnostic and Statistical 
Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR) 
(18,19). Exclusion criteria were: principle diagnosis of bulimia 
nervosa, eating disorder not otherwise specified (EDNOS), or 
psychiatric disease other than eating disorder; and the receipt of 
therapy at other centers.
VARIABLES
Sociodemographic, clinical, anthropometric 
and therapeutic variables 
Data were gathered from clinical records of the patients on 
sociodemographic variables (sex, age at admission, history of 
suicidal and/or self-harm behavior, consumption of toxic sub-
stances, consumption of psychopharmaceuticals, number of 
previous hospitalizations, and number of previous treatments 
for AN), clinical variables (R-AN or P-AN subtype, time with AN 
[“long” = ≥ 7 yrs], and physical and psychiatric comorbidities), 
and anthropometric variables (body weight [kg] and BMI [kg/ m2] 
at hospital admission and discharge, and minimum BMI [kg/ m2] 
reached during the course of their AN). Time with AN was de-
fined as the interval (in years) between the diagnosis and first 
EDU admission.
Body weight was measured every morning after voiding, with 
patients in hospital gown and bare feet. Height was measured 
at admission. The BMI was calculated as weight (kg) divided by 
the square of height (m). 
Plasma electrolytes, glucose levels, and deficiencies were 
closely monitored during the hospital stay.
NS prescriptions from psychiatrists during all hospital stays 
were gathered from the electronic prescription program for hos-
pitalized patients (ATHOS-Prisma®). NS-related study variables 
were: type of artificial feeding (natural feeding [ordinary food] 
alone, supplementation with artificial nutrition, or solely artificial 
nutrition); intake cooperation (forced/unforced); administration 
route (enteral/parenteral); nasogastric feeding (yes/no) and ad-
ministration (continuous [> 24 h] or discontinuous [3-5 bolus 
feedings/day]); types of enteral nutrition formula; vitamin and 
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mineral supplements; maximum caloric supply (Kcal/day); dos-
age (mg/day, mEq/day, or IU/day) and duration (days) of NS; and 
reason(s) for NS prescription. 
Adherence of NS prescription to CPGs
CPGs adherence was defined as the fulfillment of all recom-
mendations, considering the “degree of adherence” as the per-
centage of hospitalizations with NS prescriptions that followed all 
recommendations. Table I compiles the nutritional recommenda-
tions of APA (2006) and NICE (2004)/SMHC (2009) for patients 
with AN, and the reasons for non-adherence to CPG recommen-
dations; SMHC recommendations are the same as those in NICE 
guidelines.
Variables related to NS effectiveness, safety, 
and cost
Evaluation of NS effectiveness considered the body weight (kg) 
and BMI (kg/m2) at discharge, weight gain rate (total weight gain 
in grams during hospitalization divided by days of hospitalization), 
hospital stay (number of days from admission to discharge), time 
to relapse (months between hospital discharge and next admis-
sion), body weight maintenance (yes/no), and number of EDU 
readmissions during 12 months post-discharge. Data on hospital 
stay and EDU admissions were furnished by the clinical documen-
tation department of the hospital. Safety was evaluated according 
to the number and type of NS-related adverse effects. The NS cost 
(in euros) was the sum of direct costs for enteral nutrition formulas 
and vitamin and mineral supplements prescribed during hospital 
stays, extracted from the Pharmacy Department economic man-
agement program (ATHOS-Stock®).
STATISTICAL ANALYSIS
IBM-SPSS V.21.0 was used for the statistical analysis. Quantita-
tive variables were expressed as central tendency and dispersion 
measures and qualitative variables as absolute and relative fre-
quencies. Proportions among groups were confirmed by bivari-
ate analysis with Pearson’s Chi-square test or, when conditions 
were not met, with Fisher’s exact test. Quantitative variables were 
compared between independent groups with the Student’s t-test 
or, when the distribution was non-normal, the Mann-Whitney 
U test. The normality of variables was verified using the Sha-
piro-Wilks test. Survival was analyzed using the Kaplan-Meier 
test, comparing survival between groups with the Log Rank test 
(Mantel-Cox). p < 0.05 was considered as significant in all tests.
Table I. Nutritional recommendations for patients with anorexia nervosa during weight 
recovery, and reasons for non-adherence of nutritional support prescriptions to 
recommendations
American Psychiatric Association (APA, 2006) guidelines Reason for non-adherence
“When life-preserving nutrition must be provided to a patient who refuses to eat, nasogastric 
feeding is preferable to intravenous feeding”
“Parenteral nutrition”
“When nasogastric feeding is necessary, continuous feeding may be better tolerated by patients 
and less likely to result in metabolic abnormalities than three to four bolus feedings a day”
“Discontinuous administration of nasogastric 
enteral feeding”
“Since zinc supplements have been reported to foster weight gain in patients with AN, these 
patients may benefit from daily zinc-containing multivitamin tablets”
“Non-supplementation with zinc”
“Phosphorus, potassium and/or magnesium supplementation should be given in severely 
malnourished patients with AN (particularly those whose weight is < 70% of their healthy body 
weight)* who undergo aggressive oral, nasogastric, or parenteral refeeding, in order to prevent 
refeeding syndrome”
“Non-supplementation with phosphorus, 
potassium, and/or magnesium for severely 
malnourished* patients with AN”
National Institute for Clinical Excellence (NICE, 2004) and  
Spanish Ministry of Health and Consumption (SMHC, 2009) guidelines
Reason for non-adherence
“In some cases*, treatment with a multivitamin and/or mineral supplement in oral form is 
recommended for patients with AN during weight restoration”
“Non-supplementation with multivitamins and/
or minerals for severely malnourished* patients 
with AN”
“Total parenteral nutrition should not be used for patients with AN, unless there is significant 
gastrointestinal dysfunction”
“Parenteral nutrition”
“Feeding against the will of the patient should be an intervention of last resort in the care and 
management of AN”
“Force-feeding”
AN: anorexia nervosa. *Considered as BMI ≤ 15 kg/m² (maximum level of severity according to the WHO categories for thinness in adults).
1004 M. M. Alañón Pardo et al.
[Nutr Hosp 2019;36(5):1001-1010]
Table II. Sociodemographic, clinical and anthropometric characteristics in 72 patients 
with anorexia nervosa at first admission in the EDU










































No. previous admissions, n (%)
 No previous admission 
 1 previous admission











No. previous treatments, n (%)
 No previous treatment 
 1 previous treatment











Duration of AN, n (%)
 Short (< 7 yrs)


















Body weight at admission (kg)
Mean (SD) 41.4 (7.2) 41.8 (7.7) 40.7 (6.7) 0.552
BMI at admission (kg/m2)
Mean (SD) 15.7 (2.6) 15.9 (2.9) 15.4 (1.6) 0.440
Minimum BMI (kg/m2)
Mean (SD) 14.4 (2.1) 14.7 (2.1) 13.9 (2.2) 0.066
BMI: body mass index; EDU: eating disorders Unit; P-AN: purging anorexia nervosa; R-AN: restrictive anorexia nervosa; SD: standard deviation. *Statistical significance (p < 0.05).
ETHICAL APPROVAL
This study was approved by the Clinical Research Ethics Commit-
tee of the hospital and respected the confidentiality of personal data.
RESULTS
SOCIODEMOGRAPHIC, CLINICAL, 
ANTHROPOMETRIC AND THERAPEUTIC 
CHARACTERISTICS 
During the study period, 128 patients were hospitalized in the EDU; 
56 were excluded for: bulimia nervosa (n = 21), EDNOS (n = 20), 
principle diagnosis of psychiatric disease other than an eating disorder 
(n = 3), and continued receipt of therapy at other centers (n = 12). 
The study finally included 72 patients with R-AN (n = 45) or 
P-AN (n = 27). Table II lists their characteristics at baseline. All 
patients had malnutrition-related physical comorbidities, includ-
ing endocrine (93.1%), hydroelectrolytic (70.8%), hematologic 
(63.9%), hepatic (41.7%), gastrointestinal (33.3%), cardiovascular 
(25.0%), bone (31.9%), and renal (12.5%) disorders. No signif-
icant differences in physical comorbidities were found between 
subtypes. The presence of psychiatric comorbidities was observed 
in 56.9% of the patients, including substance-related (30.6%), 
personality (22.2%), anxiety (16.7%), and mood (12.5%) disorders. 
Substance-related disorders were more frequent (p =0.048) in 
patients with P-AN (44.4%) versus R-AN (22.2%).
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Almost half of the patients (47.2%) were admitted to EDU more 
than once (range: 1-15 admissions/patient); 177 hospitalizations 
were analyzed (112 for R-AN and 65 for P-AN), and the BMI at 
admission was ≤ 15 kg/m2 in 37.3% of these. Psychopharmaceu-
ticals were prescribed in 71.8% of the 177 hospitalizations, find-
ing no significant difference (p = 0.637) between R-AN (70.5%) 
and P-AN (73.8%) patients. Feeding was exclusively natural in 
50.8% of hospitalizations, supplemented with artificial nutrition in 
46.3%, and completely replaced with artificial nutrition in 2.8%. 
Feeding was forced in 5.6% of hospitalizations (6.3% R-AN vs 
4.6% P-AN, p = 0.748), parenteral nutrition was used in 1.7% 
(0.9% R-AN and 3.1% P-AN, p = 0.226) and nasogastric enteral 
feeding in 5.1% (6.3% R-AN and 3.1% P-AN, p = 0.489), being 
continuous (24-h) in 44.4% of cases. 
In 49.2% of hospitalizations, complete liquid enteral nutri-
tion formulas were prescribed due to “lack of cooperation with 
oral intake” (44.8%), “insufficient weight recovery” (31.1%), or 
“life-threatening BMI” (≤ 12 kg/m2) (24.1%). The mean maximum 
caloric supply via enteral nutrition was 716.9 Kcal/day (range: 
100-2,100 Kcal/day), and the mean time with enteral nutrition 
was 41.8 days (range: 12-165 days); 93.1% of the formulas 
prescribed were standard, polymeric, hypercaloric (1.5 Kcal/ml), 
and fiber-free. The macronutrient composition of the total caloric 
supply was 15-17% proteins, 49-55% carbohydrates and 30-
35% lipids.
Oral vitamin supplements were prescribed in 23.7% of hos-
pitalizations. Out of the 66 prescriptions for these supplements, 
36.4% were for multivitamins, 31.8% for vitamin D3, 25.8% 
for vitamins B1-B6-B12, 4.5% for vitamin B1, and 1.5% for 
vitamin B6. The mean duration of vitamin consumption was 
50.9 days (range: 12-174 days). Drops of vitamin D3 (66.7 
IU/drop) were administered (400-800 IU/day) to prevent and/
or treat osteoporosis from the lack of dietary vitamin D intake 
and/or sunlight exposure. Supplementation with multivitamin 
pills (2,500-3,600 IU vitamin A, 1.6-15 mg vitamin B1, 1.8-15 
mg vitamin B2, 2.6-10 mg vitamin B6, 4-10 μg vitamin B12, 
100-200 mg vitamin C, 400-500 IU vitamin D3, 15 IU vitamin 
E, 10-25 mg calcium pantothenate, 0.2 mg biotin, 19-50 mg 
nicotinamide, and 0.4-0.8 mg folic-acid per pill) or with 250-
300 mg vitamin B1, 250-300 mg vitamin B6, and/or 0.5 mg 
vitamin B12 pills was used to prevent refeeding syndrome and 
treat vitamin deficiencies. Vitamins were administered once 
daily throughout the refeeding period. Mineral supplements 
were prescribed in 26.6% of hospitalizations. Out of the 65 
prescriptions for these supplements, 44.6% were for calcium, 
38.5% for potassium, 9.2% for phosphate, and 7.7% for mag-
nesium. Calcium supplementation (500-1,500 mg/day) used 
lactogluconate/calcium carbonate pills (500 mg calcium/pill) to 
prevent and/or treat osteoporosis; potassium supplementation 
(20-80 mEq/day) used 600 mg potassium chloride capsules 
(8 mEq potassium/capsule) and/or injections of 1,491 mg 
potassium chloride (20 mEq potassium/injection); phosphate 
supplementation (800-1,000 mg/day) used monobasic sodium 
phosphate sachets (800 mg phosphate/sachet), and magne-
sium supplementation (53-212 mg magnesium/day) used pills 
of 7.17 mg magnesium bromide, 0.34 mg magnesium fluoride, 
and 125.06 mg magnesium hydroxide.
Minerals were included in the composition of 83.3% of multi-
vitamin pills (61.8-125 mg calcium, 15.6-60 mg iron, 38.9-100 
mg magnesium, 0.5-1 mg manganese, 1 mg copper, and 30-125 
mg phosphorus per pill). In 11.3% of hospital stays, zinc was 
supplemented by the daily administration of a single multivitamin 
pill with 20.6 mg zinc sulfate (7.5 mg zinc elemental). 
Oral supplements with multivitamins, potassium, phosphorus, 
and/or magnesium were prescribed in 43.9% of the 66 hospi-
talizations with admission BMI ≤ 15 kg/m2 in order to prevent 
refeeding syndrome.
ADHERENCE OF NS PRESCRIPTIONS  
TO CPGS
NS prescriptions followed all APA recommendations in 18 
(10.2%) hospitalizations and all NICE/SMHC recommendations 
in 130 (73.4%). Among hospitalizations for R-AN (n = 112), 9.8% 
adhered to APA and 73.2% to NICE/SMHC CPGs. Among hospi-
talizations for P-AN (n = 65), 10.8% adhered to APA and 73.8% 
to NICE/SMHC CPGs. Table III exhibits the adherence to CPGs 
as a function of sociodemographic, clinical, and anthropometric 
variables. Causes of “non-adherence” in the 159 hospitalizations 
that did not meet APA recommendations were “non-supplemen-
tation with zinc” (98.7%), “non-supplementation with phosphorus, 
potassium, and/or magnesium” in patients with BMI ≤ 15 kg/ m2 
(23.3%), “discontinuous administration” of nasogastric enter-
al feeding (3.1%), and “parenteral nutrition” (1.9%). Causes of 
“non-adherence” in the 47 hospitalizations that did not meet NICE/
SMHC recommendations were “non-supplementation with multivi-
tamins and/or minerals” in patients with BMI ≤ 15 kg/m2 (78.7%), 
“force-feeding” (21.3%), and “parenteral nutrition” (6.4%).
NS EFFECTIVENESS, SAFETY AND COST  
AS A FUNCTION OF ADHERENCE TO CPGs
Table IV compares the effectiveness, safety, and cost of NS in 
patients with AN between the adherence and non-adherence of 
prescriptions to the CPGs. After correcting for the longer hospital 
stay of the patients receiving nutritional supplements, the weight 
gain rate was significantly higher in patients receiving zinc sup-
plementation (Table V). A total of 65 adverse effects of the NS 
were recorded in 28.9% of hospitalizations, including dyspepsia 
(30.8%), flatulence (29.2%), abdominal distension (18.5%), ab-
dominal pain (12.3%), nausea (4.6%), regurgitation (3.1%), and 
vomiting (1.5%), which were all attributed to the enteral nutrition 
formulas. Before the initiation of NS, hypopotassemia was ob-
served in 10.2% of hospitalizations, hypophosphatemia in 1.7%, 
and hypomagnesemia in 1.2%. During NS treatment, plasma lev-
els of these electrolytes were normal. No symptoms of refeeding 
syndrome (e.g., cardiac arrest, rhabdomyolysis or encephalopathy) 
were recorded.
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Table III. Distribution of adherence of hospitalizations (n = 177) as a function of 
sociodemographic, clinical and anthropometric variables
Variable
Adherence to APA 
guidelines

























Age at admission 
 Mean (SD) 26.7 (8.5) 25.0 (8.5) 0.420 25.3 (8.5) 24.9 (8.5) 0.811
History of suicidal and/or  











































 No previous admission 
 1 previous admission

















 No previous treatment
 1 previous treatment





























AN duration, n (%)
 Short (< 7 yrs)
























Body weight at admission (kg)
Mean (SD) 40.5 (6.9) 40.4 (6.7) 0.784 41.8 (6.6) 36.5 (4.9) < 0.001*
BMI at admission (kg/m2)
Mean (SD) 15.2 (2.1) 15.3 (1.7) 0.838 15.8 (1.7) 14.0 (1.3) < 0.001*
Minimum BMI (kg/m2)
Mean (SD) 13.9 (2.4) 13.9 (2.1) 0.855 14.1 (2.1) 13.1 (1.8) 0.003*
APA: American Psychiatric Association; AN: anorexia nervosa; BMI: body mass index; NICE: National Institute for Clinical Excellence; SD: standard deviation; SMHC: 
Spanish Ministry of Health and Consumption. *Statistical significance (p < 0.05).
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No. readmissions during the 
year after discharge, n (%)
 No readmission 
 1 readmission











































































BMI: body mass index; IQR: interquartile range; NS: nutritional support; SD: standard deviation. *Statistical significance (p < 0.05).
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DISCUSSION 
NS prescriptions for these hospitalized AN patients showed a 
low degree of adherence to APA recommendations. Force-feeding 
by nasogastric tube was more frequent than parenteral nutrition, 
considered as a last resort, although nasogastric feeding was 
more often discontinuous than continuous, while the main cause 
of “non-adherence” was “non-supplementation with zinc”. Supple-
mentation with phosphorus, potassium, and/or magnesium was not 
always offered to severely malnourished patients during the first few 
days of NS treatment. NS prescriptions showed a higher degree of 
adherence to NICE/SMHC recommendations, largely attributable to 
the scant utilization of force-feeding and parenteral nutrition, while 
the main cause of “non-adherence” was non-supplementation with 
multivitamins and/or minerals for severely malnourished patients. 
Among reported prognostic factors for AN chronification (age 
at admission, history of suicidal/self-harm behavior, consumption 
of toxic substances, number of treatments and hospitalizations, 
≥ 7 yrs with AN, psychiatric comorbidities, and low body weight/
BMI) (1,20,21), the only statistically significant differences as a 
function of CPG adherence were the lower body weight and BMI at 
admission and the lower minimum BMI reached during the course 
of their AN in the NICE/SMHC non-adherence versus adherence 
group. This apparently greater severity of illness in the NICE/SMHC 
“non-adherence” group may have increased the frequency of 
force-feeding and parenteral nutrition in life-threatening situations.
Body weight and BMI at discharge were significantly lower in 
hospitalizations with “adherence” versus “non-adherence” to APA. 
After correcting for longer hospital stay in the “APA adherence” 
group, a significantly higher weight gain rate was obtained in the 
latter in comparison to the “non-adherence” group, which may be 
attributable to the zinc supplementation. Daily supplementation with 
7.5 mg elemental zinc increased the weight gain rate in these AN 
patients. This finding is consistent with two randomized, double 
blind, placebo-controlled clinical trials (16,17) in which anorexic pa-
tients receiving 28 mg or 50 mg elemental zinc daily showed higher 
weight gain and improved anxiety and depression symptoms. Zinc is 
present in large amounts in brain areas involved in food intake, body 
weight control, and serotonin metabolism, and zinc deficiencies and 
serotonergic activity disorders are frequent in anorexic patients (17). 
However, the prescription of zinc supplementation to hospitalized 
patients with AN was infrequent in the present study.
No statistically significant differences were found in body weight 
or BMI at discharge or in weight gain rate during hospitalization 
between NICE/SMHC adherence and non-adherence, likely at-
tributable to the more severe malnutrition at admission in the 
(non-adherence) group. Hospital stay was significantly shorter in 
the NICE/SMHC “adherence” versus non-adherence group, which 
may be explained by the superior nutritional status of the former 
at admission. Accordingly, force-feeding and parenteral nutrition 
do not appear to favor weight gain or reduce the hospital stay 
in hospitalized patients with AN. There have been reports that a 
greater caloric intake and weight gain are obtained by force-feed-
ing these patients with a nasogastric tube in comparison to oral 
feeding, although these benefits are not maintained over the long 
term (13,22-25). Moreover, force-feeding may damage the rela-
tionship between patients and healthcare professionals and has 
been criticized on ethical grounds (12).
CPGs recommend multivitamin and mineral supplementation in 
severely malnourished AN patients. According to the present results, 
this supplementation does not appear to increase the weight gain 
rate in hospitalized AN patients, likely due to the greater severity 
of illness (lower body weight and BMI) at admission of the patients 
who received it. A double-blind controlled clinical trial with placebo 
also found that vitamin and mineral supplementation was not useful 
for weight gain in anorexic patients and did not enhance the effects 
of pharmacological treatment (26). However, the administration of 
multivitamins with zinc proved to be the only NS component that 
significantly increased the weight gain rate in the present patients. 
Most enteral nutrition formulas were hypercaloric, the type most 
frequently indicated in AN to reduce gastric distension and hydric 
overload during refeeding (27). However, fiber-enriched formu-
las were not routinely administered, despite the benefits of fiber 
for these frequently constipated patients (27). Administration of 
enteral nutrition formulas had no effect on weight gain and was 
associated with longer hospital stays, likely due to the higher 
malnutrition severity at admission of those treated with enteral nu-
trition. These findings support the proposal that exclusively natural 
feeding should be the first option for NS in AN patients (12,27). 
It was reported that enteral nutrition formulas do not yield major 
benefits and may possibly reinforce avoidance behavior towards 
normal food (12), although other researchers observed increased 
weight gain and reduced hospital stay with the administration of 
hypercaloric formulas (13-15,23,28). 
Over the longer term, relapse was observed within 12 months 
post-discharge after 54.2% of hospitalizations, similar to previous 
observations (5), and most of the patients failed to maintain their 
body weight during this follow-up period. Nova et al. described a 
tendency for anorexic patients to reduce food intake after hospital 
discharge due to dissatisfaction with their body image, returning to 
their pre-admission size (29). In the present study, CPG adherence 
did not appear to contribute to weight maintenance or reduce the 
time to relapse or readmission rate. 
NS-related adverse effects were mild and infrequent, and vitamin 
and mineral supplements were better tolerated than enteral nutri-
tion formulas. No refeeding syndrome was observed in any hospi-
talizations. The risk of refeeding syndrome increases with parenteral 
nutrition, but this was very rarely utilized (8-10,22). The incidence 
of adverse effects appears to be higher for NS prescriptions that 
adhere to APA versus NICE/SMHC guidelines. This may be because 
the former support nasogastric tube feeding in patients who do not 
acknowledge their disease, refuse oral intake, or feel guilty when 
eating (9). Force-feeding with nasogastric tube has been associated 
with more frequent adverse effects in anorexic patients (24).
NICE/SMHC adherence was associated with a significant reduc-
tion in NS-related costs, mainly due to the shorter hospital stay. 
Enteral nutrition formulas were more frequently administered to 
patients with a greater degree of malnutrition at admission, who 
represented a higher proportion of the NICE/SMHC “non-adher-
ence” than “adherence” group, increasing costs in the former.
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One strength of this study was the setting of an EDU in which an 
AN-specific multimodal treatment program is provided; these pa-
tients are frequently admitted to general or psychiatric hospitals, in 
which multiple factors can influence treatment effectiveness. Study 
limitations include its retrospective design and the lack of random-
ization. Moreover, clinical records were used as the main source 
of information, and possible under-recording cannot be ruled out. 
CONCLUSIONS
NS prescriptions for anorexic patients showed a higher degree 
of adherence to NICE/SMHC than APA recommendations. APA 
adherence was associated with improved weight gain during hos-
pitalization but only over the short term. Patients whose NS pre-
scriptions followed all NICE/SMHC recommendations had shorter 
hospital stay and reduced costs, likely due to their more favorable 
nutritional status at admission.
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